Skip to main content
. Author manuscript; available in PMC: 2019 Oct 9.
Published in final edited form as: J Mater Chem B. 2018 Oct 9;6(43):6957–6968. doi: 10.1039/C8TB01995A

Figure 8.

Figure 8.

Comparative cytotoxicity of healthy MRC-5 and breast cancer MCF-7 cells following 72 h incubation with different doses of pure derivatives A or B and A- or B-loaded HAp/ChOSL particles. (a) Cytotoxicity at 20 nM and 300 uM A compared to A-HAp/ChOSL. (b) Cytotoxicity at 100 nM and 1.3 mM B compared to B-HAp/ChOSL. (c) Ratio of the cytotoxicity imposed onto cancerous MCF-7 cells to the cytotoxicity imposed onto healthy MRC-5 cells by pure derivatives A or B compared to A-HAp/ChOSL and B-HAp/ChOSL.